Department of Human Pathology, Kanazawa University Graduate School of Medicine, , Kanazawa, Ishikawa, Japan.
J Clin Pathol. 2014 May;67(5):396-402. doi: 10.1136/jclinpath-2013-201815. Epub 2013 Nov 29.
Primary biliary cirrhosis (PBC) is characterised by antimitochondrial antibody against the pyruvate dehydrogenase complex (PDC) and chronic non-suppurative destructive cholangitis (CNSDC). Pyruvate oxidation to acetyl-CoA by PDC is a key step in the glycolytic system. Oestrogen-related receptor-α (ERRα) is functionally activated by inducible coactivators such as peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and Bcl-3. Moreover, the PGC-1α-ERRα axis interrupts glycolytic metabolism through the upregulation of pyruvate dehydrogenase kinase, isozyme 4 (PDK4), which functionally inhibits PDC-E1α and stimulates fatty acid oxidation. In this study, we investigated the PGC-1α-ERRα axis to clarify PDC dysfunction in CNSDC of PBC.
The expression of PGC-1α, Bcl-3, ERRα, PDK4 and PDC-E1α was examined by immunohistochemistry in liver sections from patients with PBC and controls. The expression of these molecules, the activity of mitochondrial dehydrogenase and PDC, and their alterations by starvation, a treatment used to induce PGC-1α expression, were examined in cultured human biliary epithelial cells (BECs).
The nuclear expression of PGC-1α, Bcl-3 and ERRα was exclusively observed in CNSDC of PBC. Moreover, the expression of PDK4 and PDC-E1α was enhanced in CNSDC of PBC. In cultured BECs, the amplification of Bcl-3 and PDK4 mRNAs by reverse-transcription-PCR and mitochondrial dehydrogenase activity were markedly increased but PDC activity was decreased according to the upregulation of PGC-1α.
In CNSDC of PBC, the activation of the ERRα-PGC-1α axis was exclusively observed, suggesting the interference of PDC-related glycolytic function and the induction of the fatty acid degradation system. The switching of the cellular energy system is possibly associated with the pathogenesis of CNSDC in PBC.
原发性胆汁性肝硬化(PBC)的特征是针对丙酮酸脱氢酶复合物(PDC)的抗线粒体抗体和慢性非化脓性破坏性胆管炎(CNSDC)。PDC 将丙酮酸氧化为乙酰辅酶 A 是糖酵解系统中的关键步骤。雌激素相关受体-α(ERRα)通过诱导共激活剂(如过氧化物酶体增殖物激活受体 γ 共激活剂-1α(PGC-1α)和 Bcl-3)被功能激活。此外,PGC-1α-ERRα 轴通过上调丙酮酸脱氢酶激酶,同工酶 4(PDK4)中断糖酵解代谢,PDK4 功能抑制 PDC-E1α 并刺激脂肪酸氧化。在这项研究中,我们研究了 PGC-1α-ERRα 轴以阐明 PBC 的 CNSDC 中的 PDC 功能障碍。
通过免疫组织化学检查 PBC 患者和对照者肝组织切片中 PGC-1α、Bcl-3、ERRα、PDK4 和 PDC-E1α 的表达。检查这些分子的表达、线粒体脱氢酶和 PDC 的活性以及饥饿(用于诱导 PGC-1α 表达的治疗方法)对它们的改变,在培养的人胆管上皮细胞(BEC)中进行。
PGC-1α、Bcl-3 和 ERRα 的核表达仅在 PBC 的 CNSDC 中观察到。此外,PDK4 和 PDC-E1α 的表达在 PBC 的 CNSDC 中增强。在培养的 BEC 中,逆转录-PCR 和线粒体脱氢酶活性的 Bcl-3 和 PDK4 mRNA 的扩增明显增加,但根据 PGC-1α 的上调,PDC 活性降低。
在 PBC 的 CNSDC 中,仅观察到 ERRα-PGC-1α 轴的激活,表明 PDC 相关糖酵解功能的干扰和脂肪酸降解系统的诱导。细胞能量系统的转换可能与 PBC 中 CNSDC 的发病机制有关。